NEW YORK–(COMMERCIAL THREAD) – Silver Spike Investment Corp. (“SSIC”), a newly incorporated closed-end investment company that has elected to be treated as a business development company, plans to make an initial public offering of 10,714,286 common shares. The offer price is $ 14.00 per common share. SSIC has applied for approval of its common shares for listing on the NASDAQ Stock Exchange under the symbol “SSIC”. The underwriters are expected to have the option to purchase up to 1,607,143 additional common shares. The completion of the proposed offer depends on several factors, including the market and other conditions.
SSIC will be managed by Silver Spike Capital, LLC. SSIC’s investment objective will be to maximize risk-adjusted returns on equity for its shareholders. SSIC intends to achieve its investment objective by investing primarily in secured debt securities, unsecured debt securities, stock warrants and direct investments in mid-market cannabis companies and other companies in the health and wellness sector.
SSIC intends to use the net proceeds of this offering to make investments in accordance with its investment objective and strategies and for general corporate purposes.
Stifel, Nicolaus & Company, Incorporated and JMP Securities LLC are acting as co-book managers for the offering. Cantor Fitzgerald & Co., Oppenheimer & Co. Inc. and JonesTrading Institutional Services LLC act as co-managers of the offering.
A registration statement relating to these securities has been filed with the United States Securities and Exchange Commission (the “SEC”) but has not yet become effective. These securities cannot be sold and offers to buy cannot be accepted before the entry into force of the registration statement. No offer to purchase securities may be accepted and no part of the purchase price may be received until the registration statement has come into effect, and such offer may be withdrawn or revoked by you without obligation or commitment of any kind, at any time before until such time as you receive notice of acceptance of the given offer after the effective date.
Investors are advised to carefully consider the investment objectives, risks and costs and expenses of SSIC before investing. The preliminary prospectus, dated July 16, 2021, contains this and other information about SSIC and should be read carefully before investing. The information contained in the registration statement, the preliminary prospectus and hereof is not complete and is subject to change.
This press release will not constitute an offer to sell or the solicitation of an offer to buy any of the securities described above and there will be no sale of such securities in any state or jurisdiction where such an offer, solicitation or sale would be illegal prior to their registration or qualification under the securities laws of any such state or jurisdiction. The offers of these securities are made only by means of the preliminary prospectus. The SEC has not approved or disapproved these securities or approved the adequacy of the preliminary prospectus. Any statement to the contrary is a criminal offense.
These securities will be offered only by means of a preliminary prospectus forming part of the registration statement, copies of which can be obtained, when available, from: Stifel, Nicolaus & Company, Incorporated, Attention : Syndicate Department, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by email at email@example.com and JMP Securities LLC, Attention: Equity Syndicate, 600 Montgomery Street, Suite 1100, San Francisco, CA 94111, by email to firstname.lastname@example.org.
About Silver Spike Investment Corp.
Silver Spike Investment Corp. (“SSIC”) is a newly formed specialist finance company to invest in the cannabis ecosystem through direct loan investments and equity participation in private cannabis companies. SSIC elected to be treated as a business development company under the Investment Companies Act of 1940, as amended. SSIC will be managed by Silver Spike Capital, LLC. Silver Spike Capital, LLC is an investment manager focused on the cannabis and alternative health and wellness industries.
Certain information contained in this document may constitute “forward-looking statements” which involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and should not be relied on unduly. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about SSIC, its current and potential portfolio investments, industry, beliefs and opinions and assumptions. Words such as “anticipate”, “expect”, “intend”, “plan”, “will”, “may”, “continue”, “believe”, “seek”, “” should “,” targets “,” projects “,” outlook “,” potential “,” predicted “and variations of such words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the control of SSIC and are difficult to predict and could cause actual results to differ materially from those expressed or anticipated in the forward-looking statements, including, without limited thereto, the risks, uncertainties and other factors identified in documents filed by SSIC with the SEC.Investors should not place undue reliance on these forward-looking statements, which speak only as of the date on which SSIC does them. SSIC assumes no obligatio n update or revise forward-looking statements or any other information contained herein, except as required by applicable law.